Therapeutic oligonucleotides:
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Cambridge
RSC Pub.
c2008
|
| Schriftenreihe: | RSC biomolecular sciences
|
| Schlagworte: | |
| Online-Zugang: | FAW01 FAW02 Volltext |
| Beschreibung: | Includes bibliographical references and index The role of backbone modifications in oligonucleotide-based strategies -- Genasense (G3139) : an antisense Bcl-2 oligodeoxyribonucleotide with substantial clinical activity and a complex mechanism of action -- Antisense morpholino oligomers and their peptide conjugates -- Peptide-peptide nucleic acid conjugates for modulation of gene expression -- Locked nucleic acid: properties and therapeutic aspects -- Immune stimulatory oligonucleotides -- Decoy oligodeoxynucleotides to treat inflammatory diseases -- AS1411 : development of an anticancer aptamer -- Spiegelmer NOX-E36 for renal diseases -- Strategies for the delivery of oligonucleotides in vivo -- Lipid-mediated in vivo delivery of small interfering RNAs -- Vector-mediated and viral delivery of short hairpin RNAs -- Development of an RNAi-based gene therapy against HIV-1 -- RNA based therapies for treatment of HIV infection |
| Beschreibung: | 1 Online-Ressource (xvii, 343 p.) |
| ISBN: | 0854041168 1847558275 9780854041169 9781847558275 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043104679 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 151126s2008 |||| o||u| ||||||eng d | ||
| 020 | |a 0854041168 |9 0-85404-116-8 | ||
| 020 | |a 1847558275 |9 1-84755-827-5 | ||
| 020 | |a 1847558275 |c electronic bk. |9 1-84755-827-5 | ||
| 020 | |a 9780854041169 |9 978-0-85404-116-9 | ||
| 020 | |a 9780854041169 |9 978-0-85404-116-9 | ||
| 020 | |a 9781847558275 |c electronic bk. |9 978-1-84755-827-5 | ||
| 035 | |a (OCoLC)319518100 | ||
| 035 | |a (DE-599)BVBBV043104679 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 615.31 |2 22 | |
| 245 | 1 | 0 | |a Therapeutic oligonucleotides |c edited by Jens Kurreck |
| 264 | 1 | |a Cambridge |b RSC Pub. |c c2008 | |
| 300 | |a 1 Online-Ressource (xvii, 343 p.) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a RSC biomolecular sciences | |
| 500 | |a Includes bibliographical references and index | ||
| 500 | |a The role of backbone modifications in oligonucleotide-based strategies -- Genasense (G3139) : an antisense Bcl-2 oligodeoxyribonucleotide with substantial clinical activity and a complex mechanism of action -- Antisense morpholino oligomers and their peptide conjugates -- Peptide-peptide nucleic acid conjugates for modulation of gene expression -- Locked nucleic acid: properties and therapeutic aspects -- Immune stimulatory oligonucleotides -- Decoy oligodeoxynucleotides to treat inflammatory diseases -- AS1411 : development of an anticancer aptamer -- Spiegelmer NOX-E36 for renal diseases -- Strategies for the delivery of oligonucleotides in vivo -- Lipid-mediated in vivo delivery of small interfering RNAs -- Vector-mediated and viral delivery of short hairpin RNAs -- Development of an RNAi-based gene therapy against HIV-1 -- RNA based therapies for treatment of HIV infection | ||
| 650 | 7 | |a MEDICAL / Pharmacology |2 bisacsh | |
| 650 | 4 | |a Oligonucleotides / therapeutic use | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Oligonucleotides |x Therapeutic use | |
| 650 | 0 | 7 | |a Pharmakologie |0 (DE-588)4045687-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Oligonucleotide |0 (DE-588)4133456-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Oligonucleotide |0 (DE-588)4133456-5 |D s |
| 689 | 0 | 1 | |a Pharmakologie |0 (DE-588)4045687-0 |D s |
| 689 | 0 | 2 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 700 | 1 | |a Kurreck, Jens |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=496407 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-EBA | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028528870 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=496407 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=496407 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804175518179786752 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV043104679 |
| collection | ZDB-4-EBA |
| ctrlnum | (OCoLC)319518100 (DE-599)BVBBV043104679 |
| dewey-full | 615.31 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.31 |
| dewey-search | 615.31 |
| dewey-sort | 3615.31 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03147nmm a2200553zc 4500</leader><controlfield tag="001">BV043104679</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s2008 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0854041168</subfield><subfield code="9">0-85404-116-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1847558275</subfield><subfield code="9">1-84755-827-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1847558275</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">1-84755-827-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780854041169</subfield><subfield code="9">978-0-85404-116-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780854041169</subfield><subfield code="9">978-0-85404-116-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781847558275</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-1-84755-827-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)319518100</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043104679</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.31</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Therapeutic oligonucleotides</subfield><subfield code="c">edited by Jens Kurreck</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge</subfield><subfield code="b">RSC Pub.</subfield><subfield code="c">c2008</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xvii, 343 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">RSC biomolecular sciences</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">The role of backbone modifications in oligonucleotide-based strategies -- Genasense (G3139) : an antisense Bcl-2 oligodeoxyribonucleotide with substantial clinical activity and a complex mechanism of action -- Antisense morpholino oligomers and their peptide conjugates -- Peptide-peptide nucleic acid conjugates for modulation of gene expression -- Locked nucleic acid: properties and therapeutic aspects -- Immune stimulatory oligonucleotides -- Decoy oligodeoxynucleotides to treat inflammatory diseases -- AS1411 : development of an anticancer aptamer -- Spiegelmer NOX-E36 for renal diseases -- Strategies for the delivery of oligonucleotides in vivo -- Lipid-mediated in vivo delivery of small interfering RNAs -- Vector-mediated and viral delivery of short hairpin RNAs -- Development of an RNAi-based gene therapy against HIV-1 -- RNA based therapies for treatment of HIV infection</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oligonucleotides / therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oligonucleotides</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Oligonucleotide</subfield><subfield code="0">(DE-588)4133456-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Oligonucleotide</subfield><subfield code="0">(DE-588)4133456-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kurreck, Jens</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=496407</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028528870</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=496407</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=496407</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV043104679 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:17:33Z |
| institution | BVB |
| isbn | 0854041168 1847558275 9780854041169 9781847558275 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028528870 |
| oclc_num | 319518100 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | 1 Online-Ressource (xvii, 343 p.) |
| psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
| publishDate | 2008 |
| publishDateSearch | 2008 |
| publishDateSort | 2008 |
| publisher | RSC Pub. |
| record_format | marc |
| series2 | RSC biomolecular sciences |
| spelling | Therapeutic oligonucleotides edited by Jens Kurreck Cambridge RSC Pub. c2008 1 Online-Ressource (xvii, 343 p.) txt rdacontent c rdamedia cr rdacarrier RSC biomolecular sciences Includes bibliographical references and index The role of backbone modifications in oligonucleotide-based strategies -- Genasense (G3139) : an antisense Bcl-2 oligodeoxyribonucleotide with substantial clinical activity and a complex mechanism of action -- Antisense morpholino oligomers and their peptide conjugates -- Peptide-peptide nucleic acid conjugates for modulation of gene expression -- Locked nucleic acid: properties and therapeutic aspects -- Immune stimulatory oligonucleotides -- Decoy oligodeoxynucleotides to treat inflammatory diseases -- AS1411 : development of an anticancer aptamer -- Spiegelmer NOX-E36 for renal diseases -- Strategies for the delivery of oligonucleotides in vivo -- Lipid-mediated in vivo delivery of small interfering RNAs -- Vector-mediated and viral delivery of short hairpin RNAs -- Development of an RNAi-based gene therapy against HIV-1 -- RNA based therapies for treatment of HIV infection MEDICAL / Pharmacology bisacsh Oligonucleotides / therapeutic use Medizin Oligonucleotides Therapeutic use Pharmakologie (DE-588)4045687-0 gnd rswk-swf Oligonucleotide (DE-588)4133456-5 gnd rswk-swf Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf Oligonucleotide (DE-588)4133456-5 s Pharmakologie (DE-588)4045687-0 s Pharmakotherapie (DE-588)4076066-2 s 1\p DE-604 Kurreck, Jens Sonstige oth http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=496407 Aggregator Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Therapeutic oligonucleotides MEDICAL / Pharmacology bisacsh Oligonucleotides / therapeutic use Medizin Oligonucleotides Therapeutic use Pharmakologie (DE-588)4045687-0 gnd Oligonucleotide (DE-588)4133456-5 gnd Pharmakotherapie (DE-588)4076066-2 gnd |
| subject_GND | (DE-588)4045687-0 (DE-588)4133456-5 (DE-588)4076066-2 |
| title | Therapeutic oligonucleotides |
| title_auth | Therapeutic oligonucleotides |
| title_exact_search | Therapeutic oligonucleotides |
| title_full | Therapeutic oligonucleotides edited by Jens Kurreck |
| title_fullStr | Therapeutic oligonucleotides edited by Jens Kurreck |
| title_full_unstemmed | Therapeutic oligonucleotides edited by Jens Kurreck |
| title_short | Therapeutic oligonucleotides |
| title_sort | therapeutic oligonucleotides |
| topic | MEDICAL / Pharmacology bisacsh Oligonucleotides / therapeutic use Medizin Oligonucleotides Therapeutic use Pharmakologie (DE-588)4045687-0 gnd Oligonucleotide (DE-588)4133456-5 gnd Pharmakotherapie (DE-588)4076066-2 gnd |
| topic_facet | MEDICAL / Pharmacology Oligonucleotides / therapeutic use Medizin Oligonucleotides Therapeutic use Pharmakologie Oligonucleotide Pharmakotherapie |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=496407 |
| work_keys_str_mv | AT kurreckjens therapeuticoligonucleotides |